77 related articles for article (PubMed ID: 19464241)
1. The controversial role of lamivudine prophylaxis in occult HBV carriers treated with chemo-immune therapy.
D'Andrea M; Nosotti L; Pimpinelli F; Dessanti ML; Paviglianiti A; Miglioresi L; Morrone A; Petti MC
Dig Liver Dis; 2009 Nov; 41(11):839-40. PubMed ID: 19464241
[No Abstract] [Full Text] [Related]
2. Lamivudine prophylaxis in HBV carriers with haemato-oncological malignancies who receive chemotherapy.
Idilman R
J Antimicrob Chemother; 2005 Jun; 55(6):828-31. PubMed ID: 15849263
[TBL] [Abstract][Full Text] [Related]
3. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.
Lai CL; Ching CK; Tung AK; Li E; Young J; Hill A; Wong BC; Dent J; Wu PC
Hepatology; 1997 Jan; 25(1):241-4. PubMed ID: 8985298
[TBL] [Abstract][Full Text] [Related]
4. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
[TBL] [Abstract][Full Text] [Related]
5. Trial of lamivudine in hepatitis B surface antigen carriers with persistent hepatitis B core IgM antibody.
Ali HY
Saudi Med J; 2003 Sep; 24(9):996-9. PubMed ID: 12973486
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
Picardi M; Pane F; Quintarelli C; De Renzo A; Del Giudice A; De Divitiis B; Persico M; Ciancia R; Salvatore F; Rotoli B
Haematologica; 2003 Nov; 88(11):1296-303. PubMed ID: 14607759
[TBL] [Abstract][Full Text] [Related]
7. Severe reactivation of hepatitis B virus infection in a patient with hairy cell leukemia: Should lamivudine prophylaxis be recommended to HBsAg-negative, anti-HBc-positive patients?
Orlando R; Tosone G; Tiseo D; Piazza M; Portella G; Ciancia R; Martinelli V; Montante B; Rotoli B
Infection; 2006 Oct; 34(5):282-4. PubMed ID: 17033754
[TBL] [Abstract][Full Text] [Related]
8. Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection.
Arcaini L; Merli M; Rattotti S; Bruno R; Vercelli A; Lucioni M; Riboni R; Paulli M
J Clin Oncol; 2011 Jun; 29(18):e543-5. PubMed ID: 21482990
[No Abstract] [Full Text] [Related]
9. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy.
Tanaka E; Matsumoto A; Yoshizawa K; Maki N
Intervirology; 2008; 51 Suppl 1():3-6. PubMed ID: 18544941
[TBL] [Abstract][Full Text] [Related]
11. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.
Coiffier B
Cancer Invest; 2006; 24(5):548-52. PubMed ID: 16939967
[TBL] [Abstract][Full Text] [Related]
13. Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation.
Hashino S; Nozawa A; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Hige S; Asaka M
Bone Marrow Transplant; 2002 Feb; 29(4):361-3. PubMed ID: 11896435
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
Jain MK; Comanor L; White C; Kipnis P; Elkin C; Leung K; Ocampo A; Attar N; Keiser P; Lee WM
J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
He YF; Li YH; Wang FH; Jiang WQ; Xu RH; Sun XF; Xia ZJ; Huang HQ; Lin TY; Zhang L; Bao SP; He YJ; Guan ZZ
Ann Hematol; 2008 Jun; 87(6):481-5. PubMed ID: 18299831
[TBL] [Abstract][Full Text] [Related]
16. Anti-viral prophylaxis in inactive hepatitis B virus carriers with hemato-oncological malignancies who receive chemotherapy.
Idilman R
Minerva Gastroenterol Dietol; 2006 Mar; 52(1):39-45. PubMed ID: 16554705
[TBL] [Abstract][Full Text] [Related]
17. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
Uhm JE; Kim K; Lim TK; Park BB; Park S; Hong YS; Lee SC; Hwang IG; Koh KC; Lee MH; Ahn JS; Kim WS; Jung CW; Kang WK
Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252
[TBL] [Abstract][Full Text] [Related]
18. Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers.
Kohmoto M; Enomoto M; Tamori A; Habu D; Takeda T; Kawada N; Sakaguchi H; Seki S; Shiomi S; Nishiguchi S
J Med Virol; 2005 Feb; 75(2):235-9. PubMed ID: 15602726
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion.
Pérez-Grande R; Gutiérrez-Zufiaurre N; Muñoz-Criado S; Blázquez de Castro AM; Vázquez López L; González San Martín F; García Rodríguez JA; Muñoz Bellido JL
Diagn Microbiol Infect Dis; 2009 May; 64(1):80-2. PubMed ID: 19304434
[TBL] [Abstract][Full Text] [Related]
20. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
Knöll A; Boehm S; Hahn J; Holler E; Jilg W
J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
